Total Payments
$15,232
2024 Payments
$4,988
Companies
77
Transactions
791
Medicare Patients
3,509
Medicare Billing
$309,843
Payment Breakdown by Category
Food & Beverage$14,716 (96.6%)
Other$332.64 (2.2%)
Education$182.65 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,716 | 773 | 96.6% |
| Entertainment | $191.24 | 1 | 1.3% |
| Education | $182.65 | 7 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $141.40 | 10 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,907 | 114 | $0 (2024) |
| ABBVIE INC. | $1,137 | 57 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,124 | 39 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $721.44 | 24 | $0 (2024) |
| CSL Behring | $649.39 | 25 | $0 (2024) |
| Lilly USA, LLC | $508.91 | 26 | $0 (2024) |
| PFIZER INC. | $504.17 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $503.16 | 35 | $0 (2024) |
| Amgen Inc. | $473.40 | 29 | $0 (2024) |
| ARGENX US, INC. | $455.46 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,988 | 204 | Alexion Pharmaceuticals, Inc. ($689.95) |
| 2023 | $3,556 | 172 | AbbVie Inc. ($415.38) |
| 2022 | $1,150 | 55 | Biohaven Pharmaceutical Holding Company Ltd. ($425.12) |
| 2021 | $113.19 | 1 | GENZYME CORPORATION ($113.19) |
| 2020 | $524.34 | 24 | ACADIA Pharmaceuticals Inc ($141.13) |
| 2019 | $2,152 | 133 | UCB, Inc. ($337.16) |
| 2018 | $1,420 | 105 | UCB, Inc. ($255.45) |
| 2017 | $1,329 | 97 | UCB, Inc. ($270.95) |
All Payment Transactions
791 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: Neurology | ||||||
| 12/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Opioid Use Disorder | ||||||
| 12/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Opioid Use Disorder | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/13/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Immune | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Rare Disease | ||||||
| 12/06/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Opioid Use Disorder | ||||||
| 12/03/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: Neurology | ||||||
| 12/03/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: Neurology | ||||||
| 12/02/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $25.95 | General |
| Category: NEUROLOGY | ||||||
| 11/27/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/26/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Neurology | ||||||
| 11/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Opioid Use Disorder | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 880 | 1,108 | $231,240 | $76,107 |
| 2022 | 12 | 914 | 1,180 | $226,588 | $81,571 |
| 2021 | 13 | 879 | 1,098 | $213,254 | $80,671 |
| 2020 | 10 | 836 | 1,041 | $195,632 | $71,494 |
Total Patients
3,509
Total Services
4,427
Medicare Billing
$309,843
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 96 | 100 | $34,126 | $11,907 | 34.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 193 | 362 | $36,200 | $11,738 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $26,093 | $8,359 | 32.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 65 | 114 | $22,578 | $8,072 | 35.8% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 76 | 76 | $19,380 | $6,778 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 76 | $18,186 | $6,592 | 36.2% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 94 | 94 | $14,476 | $4,872 | 33.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 27 | 27 | $12,579 | $4,084 | 32.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 64 | 65 | $11,180 | $2,788 | 24.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 24 | 24 | $7,568 | $2,293 | 30.3% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 13 | 13 | $5,161 | $1,991 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,834 | $1,657 | 34.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 12 | 12 | $5,084 | $1,567 | 30.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 29 | 29 | $6,438 | $1,148 | 17.8% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 14 | 14 | $3,360 | $909.58 | 27.1% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 13 | 13 | $2,665 | $877.47 | 32.9% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 11 | 12 | $1,332 | $474.43 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 104 | 116 | $34,212 | $15,197 | 44.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 232 | 442 | $43,903 | $14,728 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 73 | 73 | $29,443 | $11,676 | 39.7% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 143 | 143 | $22,214 | $8,197 | 36.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 53 | 88 | $17,527 | $6,615 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 64 | $13,607 | $5,197 | 38.2% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 56 | 56 | $14,440 | $5,122 | 35.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 19 | 19 | $9,665 | $3,089 | 32.0% |
About Dr. Greg Smith, MD
Dr. Greg Smith, MD is a Neurology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649257866.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Smith, MD has received a total of $15,232 in payments from pharmaceutical and medical device companies, with $4,988 received in 2024. These payments were reported across 791 transactions from 77 companies. The most common payment nature is "Food and Beverage" ($14,716).
As a Medicare-enrolled provider, Smith has provided services to 3,509 Medicare beneficiaries, totaling 4,427 services with total Medicare billing of $309,843. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Louisville, KY
- Active Since 12/29/2005
- Last Updated 12/02/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649257866
Products in Payments
- Vimpat (Drug) $784.79
- ULTOMIRIS (Biological) $772.54
- Briviact (Drug) $734.60
- NUPLAZID (Drug) $721.44
- Hizentra (Biological) $649.39
- NURTEC ODT (Drug) $456.37
- UBRELVY (Drug) $416.48
- Aimovig (Biological) $401.02
- VYVGART (Drug) $394.10
- BOTOX (Biological) $384.55
- BRIUMVI (Drug) $384.19
- BAFIERTAM (Drug) $320.78
- QULIPTA (Drug) $315.76
- Leqembi (Drug) $272.19
- COMIRNATY (Biological) $268.54
- Rystiggo (Drug) $267.62
- Gamunex-C (Biological) $261.83
- FYCOMPA (Drug) $229.58
- PANZYGA (Biological) $229.57
- NUEDEXTA (Drug) $207.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Louisville
Adolfo Ramirez-Zamora, M.d, M.D
Neurology — Payments: $360,493
Neurology $360,493
Dr. Kristi Nord, M.d, M.D
Neurology — Payments: $342,417
Neurology $342,417
Dr. Brian Plato, D.o, D.O
Neurology — Payments: $309,983
Neurology $309,983
Dr. Angela Hardwick, M.d, M.D
Neurology — Payments: $259,489
Neurology $259,489
Jeffrey Frank, Md, MD
Neurology — Payments: $232,884
Neurology $232,884
Vinay Puri, M.d, M.D
Neurology — Payments: $225,192
Neurology $225,192